MarketCap
Facebook
X
Telegram
Orthofix Medical Net Debt | OFIX
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.5 M | 77.8 M | 63.5 M | -29.8 M | -66.1 M | - | -46.9 M | -69.6 M | -81.2 M | -39.6 M | -63.7 M | -36.8 M | -10.5 M | -11 M | 177 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 177 M | -81.2 M | -4.18 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Medical devices industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
15.2 M | $ 43.32 | 0.04 % | $ 1.99 B |  USA |
 |
Bruker Corporation
BRKR
|
1.59 B | $ 59.67 | 0.18 % | $ 9.06 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-110 M | $ 8.73 | 1.16 % | $ 637 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
3.85 M | $ 14.97 | 13.03 % | $ 424 M | USA |
 |
Conformis
CFMS
|
-26.2 M | - | - | $ 16.4 M | USA |
 |
CONMED Corporation
CNMD
|
802 M | $ 45.8 | 3.31 % | $ 1.42 B | USA |
 |
Cytosorbents Corporation
CTSO
|
11 M | $ 4.91 | 0.75 % | $ 306 M | USA |
 |
Delcath Systems
DCTH
|
-42.5 M | $ 15.96 | 1.8 % | $ 572 M | USA |
 |
Eargo
EAR
|
-97.8 M | - | - | $ 10.2 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.64 B | $ 5.7 | 0.43 % | $ 770 M | USA |
 |
Electromed
ELMD
|
-10.5 M | $ 27.57 | 0.11 % | $ 228 M | USA |
 |
Establishment Labs Holdings
ESTA
|
174 M | $ 67.76 | 3.69 % | $ 2.01 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
-2.32 B | $ 86.82 | 0.51 % | $ 50.8 B | USA |
 |
Align Technology
ALGN
|
-980 M | $ 148.17 | 4.36 % | $ 10.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
-5.12 M | $ 2.88 | 2.45 % | $ 63.5 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
506 M | $ 15.53 | 2.76 % | $ 1.19 B | USA |
 |
Inogen
INGN
|
-86.3 M | $ 5.09 | 2.55 % | $ 135 M | USA |
 |
Inspire Medical Systems
INSP
|
-72.7 M | $ 69.06 | 0.57 % | $ 2.03 B | USA |
 |
IRIDEX Corporation
IRIX
|
-5.23 M | $ 0.63 | 0.08 % | $ 10.7 M | USA |
 |
IRadimed Corporation
IRMD
|
-52.1 M | $ 86.35 | 0.08 % | $ 1.1 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.18 B | $ 126.32 | 0.02 % | $ 4.39 B | USA |
|
LENSAR
LNSR
|
-10.2 M | $ 7.15 | 0.14 % | $ 85.5 M | USA |
 |
Medigus Ltd.
MDGS
|
-6.43 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Apyx Medical Corporation
APYX
|
3.52 M | $ 2.95 | 1.37 % | $ 121 M | USA |
 |
Cutera
CUTR
|
-140 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
24.4 B | $ 89.3 | 0.08 % | $ 114 B | USA |
 |
MiMedx Group
MDXG
|
-148 M | $ 4.77 | 0.2 % | $ 705 M | USA |
 |
Accuray Incorporated
ARAY
|
114 M | $ 0.23 | 1.0 % | $ 28.2 M | USA |
 |
Myomo
MYO
|
-2.42 M | $ 1.64 | 0.3 % | $ 68.6 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-44.4 M | $ 0.7 | 0.45 % | $ 45.4 M | Israel |
 |
Nemaura Medical
NMRD
|
9.93 M | - | -17.8 % | $ 2.74 M |  Britain |
 |
InspireMD
NSPR
|
-5.65 M | $ 0.74 | 0.16 % | $ 47.6 M | Israel |
 |
Outset Medical
OM
|
63 M | $ 3.09 | 5.45 % | $ 47 K | USA |
 |
Boston Scientific Corporation
BSX
|
9.26 B | $ 44.62 | 0.31 % | $ 66.1 B | USA |
 |
Insulet Corporation
PODD
|
218 M | $ 136.49 | 0.01 % | $ 9.6 B | USA |
 |
Profound Medical Corp.
PROF
|
-55 M | $ 5.74 | 0.16 % | $ 174 M |  Canada |
 |
Quanterix Corporation
QTRX
|
7.4 M | $ 3.16 | 4.93 % | $ 135 M | USA |
 |
AVITA Medical
RCEL
|
29.1 M | $ 10.95 | 0.61 % | $ 305 M |  Australia |
 |
Neovasc
NVCN
|
-51 M | - | - | $ 111 M | Canada |
 |
Sintx Technologies
SINT
|
-898 K | $ 1.78 | 3.98 % | $ 4.94 M | USA |
 |
Smith & Nephew plc
SNN
|
-341 M | $ 26.82 | 0.07 % | $ 23.3 B | Britain |
 |
Inari Medical
NARI
|
-6.55 M | - | - | $ 4.23 B | USA |
 |
Sensus Healthcare
SRTS
|
-21.6 M | $ 3.03 | 0.32 % | $ 49.5 M | USA |
 |
Stryker Corporation
SYK
|
11 B | $ 273.4 | 0.38 % | $ 104 B | USA |
 |
Tactile Systems Technology
TCMD
|
-75.4 M | $ 22.43 | 0.55 % | $ 513 M | USA |
 |
TELA Bio
TELA
|
5.33 M | $ 1.3 | 0.71 % | $ 61 M | USA |
 |
Viemed Healthcare
VMD
|
-1.01 M | $ 8.8 | 1.24 % | $ 342 M | USA |
 |
Varex Imaging Corporation
VREX
|
225 M | $ 18.45 | 0.05 % | $ 764 M | USA |
 |
Sientra
SIEN
|
31.1 M | - | -16.59 % | $ 10.3 M | USA |